These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26261608)

  • 1. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
    Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
    Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
    Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
    BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter.
    Dong W; Li J; Huang Y; Zhang H; Shan Z; Teng W
    Med Sci Monit; 2012 Sep; 18(9):BR351-5. PubMed ID: 22936184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.
    Dong WW; Li J; Li J; Zhang P; Wang ZH; Sun W; Zhang H
    Int J Exp Pathol; 2018 Feb; 99(1):15-21. PubMed ID: 29655286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
    Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
    Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma.
    Pyo JS; Kang G; Kim DH; Chae SW; Park C; Kim K; Do SI; Lee HJ; Kim JH; Sohn JH
    Pathol Res Pract; 2013 Apr; 209(4):228-32. PubMed ID: 23528368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
    Kim HS; Lee JJ; Do SI; Kim K; Do IG; Kim DH; Chae SW; Sohn JH
    Int J Clin Exp Pathol; 2015; 8(5):5695-701. PubMed ID: 26191283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MRP1 and ABCG2 is associated with adverse clinical outcomes of papillary thyroid carcinoma with a solid component.
    Ohashi R; Kawahara K; Namimatsu S; Okamura R; Igarashi T; Sugitani I; Naito Z
    Hum Pathol; 2017 Sep; 67():11-17. PubMed ID: 28411177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
    Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
    Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
    Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D
    Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
    Hou X; Jiang L; Chen C; Zhu X; Ge M
    Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
    Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG
    Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 15. Loss of ERβ expression in papillary thyroid carcinoma is associated with recurrence in young female.
    Ahn HY; Kim MS; Kim MJ; Cho SY; Kim YA; Lee GH; Lee BC; Park YJ; Yi KH
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):300-6. PubMed ID: 24801822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
    Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
    Meng XY; Zhang Q; Li Q; Lin S; Li J
    J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
    Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
    Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
    Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
    Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.